Featured Insights
-
Navigating Commercial Logistics: Key Considerations For Emerging CGT Manufacturers
8/27/2025
A successful cell and gene therapy launch requires a logistics strategy that keeps patients at the center, plans for disruptions, and prepares for future growth and global expansion.
-
Discover The Path To Oncology Success
8/22/2025
The oncology landscape is brimming with innovative therapies and new treatment approaches. Successful commercialization requires a well-orchestrated strategy to bring these complex products to market.
-
Optimizing Commercial Distribution As You Prepare To Launch Your CGT
7/29/2025
An effective commercial distribution strategy is crucial for new cell and gene therapies, helping manufacturers navigate challenges and ensure patient access.
-
Creating A Compliant And Scalable CGT Logistics Launch Plan
6/12/2025
As cell and gene therapies advance to commercialization, biopharma companies face immense logistical hurdles. A customized, end-to-end strategy is crucial for ensuring product integrity and market success.
-
ThinkLive Cell and Gene Therapy Summit 2025 Summary
6/11/2025
From patient support to intricate logistics, ThinkLive CGT Summit 2025 leaders tackled the essential commercial strategies needed to deliver these innovative therapies to patients globally.
-
Navigating Regulatory Complexity In CGT Development, Commercialization
5/28/2025
To successfully commercialize cell and gene therapies, understanding evolving US regulatory mandates is key. Consider these strategies to avoid delays and ensure compliance.